Nakatsuka K - Search Results

1

[Exercise and physical therapy of osteoporosis].

Nakatsuka K, Nishizawa Y. Nakatsuka K, et al. Nihon Rinsho. 1990 Dec;48(12):2927-35. Nihon Rinsho. 1990. PMID: 2086857 Japanese. No abstract available.

2

[Osteoporosis: the Japanese clinical statistical data].

Nakatsuka K, Nishizawa Y. Nakatsuka K, et al. Nihon Rinsho. 2002 Jan;60 Suppl 1:417-24. Nihon Rinsho. 2002. PMID: 11838148 Review. Japanese. No abstract available.

3

[Biochemical markers for bone metabolism--overview].

Nakatsuka K, Nishizawa Y. Nakatsuka K, et al. Nihon Rinsho. 2002 Mar;60 Suppl 3:220-7. Nihon Rinsho. 2002. PMID: 11979911 Review. Japanese. No abstract available.

4

[Guideline for adequate use of metabolic bone markers in osteoporosis].

Nishizawa Y, Nakatsuka K. Nishizawa Y, et al. Among authors: nakatsuka k. Nihon Rinsho. 2004 Feb;62 Suppl 2:325-32. Nihon Rinsho. 2004. PMID: 15035146 Review. Japanese. No abstract available.

5

[Effects of long-term administration of alfacalcidol on bone mass and bone metabolism in patients with primary osteoporosis--comparison with calcium preparations].

Nakatsuka K, Inaba M, Aratani H, Iba K, Sato T, Koike T, Miki T, Nishizawa Y, Morii H. Nakatsuka K, et al. Nihon Ronen Igakkai Zasshi. 1997 Jul;34(7):569-76. doi: 10.3143/geriatrics.34.569. Nihon Ronen Igakkai Zasshi. 1997. PMID: 9388377 Free article. Clinical Trial. Japanese.

6

[Effect of alfacalcidol on bone and calcium metabolism in elderly women].

Saito S, Nakatsuka K, Miki T, Naka H, Kitatani K, Nishizawa Y, Morii H. Saito S, et al. Among authors: nakatsuka k. Nihon Ronen Igakkai Zasshi. 2002 Jan;39(1):62-8. doi: 10.3143/geriatrics.39.62. Nihon Ronen Igakkai Zasshi. 2002. PMID: 11857976 Free article. Japanese.

7

Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis.

Miki T, Nakatsuka K, Naka H, Kitatani K, Saito S, Masaki H, Tomiyoshi Y, Morii H, Nishizawa Y. Miki T, et al. Among authors: nakatsuka k. J Bone Miner Metab. 2003;21(3):161-5. doi: 10.1007/s007740300025. J Bone Miner Metab. 2003. PMID: 12720050 Clinical Trial.

8

Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.

Kitatani K, Nakatsuka K, Naka H, Miki T, Morii H, Nishizawa Y. Kitatani K, et al. Among authors: nakatsuka k. J Bone Miner Metab. 2003;21(4):217-24. doi: 10.1007/s00774-003-0412-z. J Bone Miner Metab. 2003. PMID: 12811626 Clinical Trial.

9

Preferential reductions of paraarticular trabecular bone component in ultradistal radius and of calcaneus ultrasonography in early-stage rheumatoid arthritis.

Inaba M, Nagata M, Goto H, Kumeda Y, Kobayashi K, Nakatsuka K, Miki T, Yamada S, Ishimura E, Nishizawa Y. Inaba M, et al. Among authors: nakatsuka k. Osteoporos Int. 2003 Aug;14(8):683-7. doi: 10.1007/s00198-003-1427-y. Epub 2003 Jul 22. Osteoporos Int. 2003. PMID: 12879221

10

Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.

Okabe R, Inaba M, Nakatsuka K, Miki T, Naka H, Moriguchi A, Nishizawa Y. Okabe R, et al. Among authors: nakatsuka k. J Bone Miner Metab. 2004;22(2):127-31. doi: 10.1007/s00774-003-0460-4. J Bone Miner Metab. 2004. PMID: 14999523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters